SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Sick Visit — Jackie Robinson

PatientJackie Robinson
Date of birth1974-01-31
IdentifiersMRN HR-ML037-SYN; SSN (made up) 000-37-2286
Document date2026-08-17
AuthorMarcus Delacroix-Hale, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

A blister on the right heel, found last night. [S]

History of Present Illness

Mr. Robinson asked for a same-day visit. Two days ago he wore new dress shoes for a long day of meetings and a dinner. Last night he found blood on his right sock; he had felt nothing, because his feet are numb, and could not see the heel well, so he used the magnifying mirror and bright lamp he was given and saw a broken blister. He has had no fever, chills, spreading redness or drainage. His glucose readings on the talking meter have run 150 to 210 mg/dL. Separately, he had the regadenoson stress test five days ago; the cardiologist found a small area of reduced blood flow at the bottom of the heart with normal pumping, started metoprolol and nitroglycerin to carry, and chose medical treatment. His chest tightness on stairs has been less since, and he has not needed the nitroglycerin. His vision is a little clearer since the first eye injections. [S]

ElementDetail
OnsetFound last night; new shoes worn two days ago
LocationBack of the right heel
SeverityPainless because of neuropathy
Associated signs and symptomsNo fever, spreading redness or drainage
ContextLoss of protective sensation and peripheral artery disease; low vision limits foot checks
HeartStress test five days ago; metoprolol and nitroglycerin started by cardiology; chest tightness less

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or chills
IntegumentaryPositiveBlister on the right heel; no other skin breaks
CardiovascularPositiveChest tightness on stairs, less since metoprolol; calf pain after about a block
EndocrineNegativeNo low blood sugar
EyesPositiveVision still blurred, a little clearer

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 1,000 mg oral tablet, one tablet twice daily with mealsOne tablet twice daily with mealsOral route2025-03-03activeS
Insulin glargine 100 units/mL pen, 30 units at bedtime, adjusted by the written plan: 2 units each week while fasting glucose is above 160 mg/dL, and 4 units less for any reading below 70At bedtime, by the gradual titration planSubcutaneous route2025-03-03activeS
Lisinopril 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2025-03-03 to 2026-07-29completedS
Atorvastatin 80 mg oral tablet, one tablet daily (increased from 40 mg at intake)One tablet dailyOral route2026-07-27activeS
Aspirin 81 mg delayed-release oral tablet, one tablet dailyOne tablet dailyOral route2025-03-03activeS
Glucagon 3 mg nasal powder, one spray into the nose for severe low blood sugar; may repeat once after 15 minutesAs needed for severe low blood sugarNasal route2026-07-27activeS
Metoprolol succinate extended-release 25 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-08-12activeS
Nitroglycerin 0.4 mg sublingual tablet, one under the tongue for chest pain, repeated every five minutes up to three; call 911 if pain is not better five minutes after the firstAs needed for chest pain, up to three dosesSublingual route2026-08-12activeS
Lisinopril 40 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eatingOne tablet daily, with sick-day rulesOral route2026-07-29activeS
Empagliflozin 10 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating, and before surgery or a colonoscopy preparationOne tablet daily, with sick-day rulesOral route2026-07-29activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-08-17Body height180cmS
2026-08-17Body weight103.2kgS
2026-08-17Body mass index (BMI) [Ratio]31.9kg/m2S
2026-08-17Systolic blood pressure136mm[Hg]S
2026-08-17Diastolic blood pressure84mm[Hg]S
2026-08-17Heart rate64/minS
2026-08-17Respiratory rate16/minS
2026-08-17Body temperature36.7CelS
2026-08-17Oxygen saturation in Arterial blood by Pulse oximetry97%S

Physical Exam

Vital signs recorded on 2026-08-17; see the Vital Signs section. [S]

SystemFinding
GeneralWell; temperature 36.7 °C; blood pressure 136/84, pulse 64
Right footUnroofed blister on the back of the heel, 2.5 by 2 cm, pink moist base, no slough, no surrounding redness, warmth, swelling or odor; does not probe to bone; dorsalis pedis and posterior tibial pulses faint; capillary refill slow
Left footIntact skin; callus under the first metatarsal head; pulses faint
CardiovascularRegular rhythm; no murmur

Problems

ProblemClinical statusVerificationCodeProvenance
Blurred vision in both eyes, worse over two months, with new floaters in the right eye for four days; acuity by Snellen chart 20/200 right and 20/80 left; undilated view poor on the right; urgent retina examination arrangedresolvedconfirmed H53.8S — Synthetic presenting finding, superseded by the retinal diagnosis two days later.
Tightness in the chest on climbing stairs for two months, easing with rest; ECG without acute change; cardiology evaluation with a stress test arrangedresolvedconfirmed R07.89S — Synthetic presenting finding, superseded by the coronary diagnosis after the stress test.
Type 2 diabetes for about fifteen years, on metformin and basal insulin, with hyperglycemia (A1c 10.4%)activeconfirmed E11.65S — Synthetic modern episode linked to his documented diabetes.
Proliferative diabetic retinopathy in both eyes with center-involving diabetic macular edema (central subfield 412 microns right, 468 left); best-corrected acuity 35 letters right and 56 letters leftactiveconfirmed E11.3513S — Synthetic retinal findings anchored to his documented loss of vision.
Vitreous hemorrhage in the right eye from proliferative retinopathy; retina attached on ultrasoundactiveconfirmed H43.11S — Synthetic finding.
Hypertension with chronic kidney disease, above goal on lisinopril 20 mg (152/92 mmHg)activeconfirmed I12.9S — Synthetic modern episode linked to his documented high blood pressure.
Diabetic kidney disease with albuminuria (urine albumin-to-creatinine ratio 86 mg/g, also raised last year) and eGFR 79activeconfirmed E11.22S — Synthetic kidney findings.
Chronic kidney disease G2 A2activeconfirmed N18.2S — Synthetic kidney finding.
Peripheral artery disease of both legs with calf pain after about one block of walking; faint foot pulsesactiveconfirmed E11.51S — Synthetic modern episode linked to the documented artery damage in his legs.
Diabetic peripheral neuropathy: loss of protective sensation in both feet on monofilament testingactiveconfirmed E11.42S — Synthetic modern episode linked to the documented nerve damage in his legs.
History of two mild strokes a year ago, without lasting weaknessactiveconfirmed Z86.73S — Synthetic modern coding of the documented strokes.
Hyperlipidemia: LDL 142 mg/dL on atorvastatin 40 mg, far above the goal below 55 mg/dLactiveconfirmed E78.5S — Synthetic laboratory finding.
Bereavement: his eldest son died in a car crash six weeks agoactiveconfirmed Z63.4S — Synthetic modern coding of a documented loss; grief is treated as grief, not as a disorder.
Coronary artery disease with stable angina on climbing stairs: a small reversible inferior perfusion defect on regadenoson stress imaging, ejection fraction 56%; medical therapy chosen with cardiologyactiveconfirmed I25.119S — Synthetic coronary diagnosis anchored to his documented heart disease; no heart attack is recorded before the episode.
Friction blister of the right heel from new shoes, unroofed, 2.5 by 2 cm, clean base, without infection, in a neuropathic foot with peripheral artery diseaseactiveconfirmed S90.821AS — Synthetic intercurrent problem at an unscheduled visit; it does not echo a documented event.

Assessment and Plan

Follow-up: Visiting nurse from tomorrow; podiatry within two days; review in nine days at the four-week visit with the ankle-brachial index. Next scheduled visit 2026-08-26: four weeks after the new medicines: potassium and creatinine, blood pressure, ankle-brachial index, feet, mood, and the second eye injections. [S]